Posted by Michael Wonder on 08 Feb 2024
HLS announces that Vascepa is now reimbursed by British Columbia's Provincial Drug Plan
6 February 2024 - Public reimbursement for Vascepa is now available in Ontario, Quebec, British Columbia, Saskatchewan, New Brunswick, Northwest Territories, Veterans Affairs and for the Non-Insured Health Benefits program for First Nations and Inuit peoples.
HLS Therapeutics announces that it has entered into a Product Listing Agreement with the province of British Columbia, for the listing and public reimbursement of Vascepa (icosapent ethyl). The PLA with BC PharmaCare is effective 6 February 2024.
